Illumina to Shake Off the Shorts
Back in September, I believed the shares of Illumina (ILMN) would trade flat to down while investors waited for clarity regarding the size of the National Institutes of Health budget. As it turns out, the NIH budget was spared the worst, but stock was just about cut in half.
Earlier this week the shares rallied on the announcement that Illumina would begin selling a fantastic new genetic sequencing machine, the HiSeq 2500. Hoping to steal Illumina's thunder, Life Technologies (LIFE) rushed out a rival machine on the same day. Both companies claim their machines can map a genome in a single day. Both machines are expected to ship later this year....476 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.